Baader Bank Aktiengesellschaft
BankPosition in AXSM — Axsome Therapeutics, Inc.
CIK 1542629
Unterschleissheim, 2M
Position in AXSM
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$489,540
-$573,972 QoQ
Shares Held
2,000
-65.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#324
of 500 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Baader Bank Aktiengesellschaft holds $22,123,898 across 12 Biotechnology names. AXSM ranks #7 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BNTX |
BioNTech SE
|
119,411 | $11,111,193 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,777 | $5,849,989 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,488 | $927,827 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
1,800 | $669,006 | |
| 5 | EXEL |
Exelixis, Inc.
|
11,000 | $598,510 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
14,068 | $497,866 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
This page
|
2,000 | $489,540 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
5,900 | $481,263 |
All Filings in AXSM
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $489,540 | 2,000 | Shares | Sole | 2026-07-23 | |
| 2025-12-31 | $1,063,512 | 5,823 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $256,866 | 2,115 | Shares | Sole | 2025-11-06 | |
| No filing history on record for this holder in this stock. | ||||||